Production of IL-12, IL-18 and TNF-α by alveolar macrophages in hypersensitivity pneumonitis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 21, Issue 3, 2004, Pages 199-203

  Chen, Baomin ^a   Tong, Zhaohui ^a   Nakamura, Shinobu ^b   Costabel, Ulrich ^a,d   Guzman, Josune ^b,c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d RUHRLANDKLINIK   (Germany)

Author keywords

Alveolar macrophages; Cytokine production; Hypersensitivity pneumonitis

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 18; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLERGIC PNEUMONITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG ALVEOLUS MACROPHAGE; LYMPHOCYTE; MALE; PRIORITY JOURNAL;

ALVEOLITIS, EXTRINSIC ALLERGIC; CELL CULTURE TECHNIQUES; FEMALE; HUMANS; INTERLEUKIN-12; INTERLEUKIN-18; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 8144221746     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Costabel U: The alveolitis of hypersensitivity pneumonitis. Eur Respir J 1988; 1: 5-9.
2. Schuyler M, Gott K, Cherne A: Mediators of hypersensitivity pneumonitis. J Lab Clin Med 2000; 136: 29-38.
3. Yamasaki H, Ando M, Brazer W, Center DM, Cruikshank WW: Polarized type 1 cytokine profile in broncho alveolar lavage T cells of patients with hypersensitivity pneumonitis. J Immunol 1999; 163: 3516-23.
4. Gudmundsson G, Monick M, Hunninghake GW: IL-12 modulates expression of hypersensitivity pneumonitis. J Immunol 1998; 161: 991-9.
5. Yoshimoto T, Takeda K, Tanaka T, et al: IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-γ production. J Immunol 1998; 161: 3400-7.
6. Wittmann M, Larsson VA, Schmidt P, Begemann G, Kapp A, Werfel T: Suppression of interleukin-12 production by human monocytes after preincubation with lipopolysaccaride. Blood 1999; 94: 1717-26.
7. Dinarello CA: IL-18: A Th1-inducing proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999; 103 (I Pt 1): 11-24.
8. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H: Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001; 19: 423-74.
9. Akira S: The role of IL-18 in innate immunity. Curr Opin Immunol 2000; 12: 59-63.
10. Sisson SD, Dinarello CA: Production of interleukin-1α, interleukin-1β and tumor necrosis factor by human mononuclear cells stimulated with granulocyte-macrophage colony-stimulating factor. Blood 1988; 72: 1368-74.
11. Gudmundsson G, Bosch A, Davidson BL, Berg DJ, Hunninghake GW: Interleukin-10 modulates the severity of hypersensitivity pneumonitis in mice. Am Respir Cell Mol Biol 1998; 19: 812-18.
12. Chang JT, Segal BM, Nakanishi K, Okamura H, Shevach EM: The costimulatory effect of IL-18 on the induction of antigen-specific IFN-gamma production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor beta2 subunit. Eur J Immunol 2000; 30: 1113-19.
13. Denis M, Bedard M, Laviolette M, Cormier Y: A study in monokine release and natural killer activity in the bronchoalveolar lavage of subjects with farmer's lungs. Am Rev Respir Dis 1993; 147: 934-9.
14. Denis M, Cormier Y, Fournier M, Tardif J, Laviolette M: Tumor necrosis factor plays an essential role in determining hypersensitivity pneumonitis in a mouse model. Am J Respir Cell Mol Biol 1991; 5(5): 477-83.
15. Shigehara K, Shijubo N, Ohmichi M, et al: IL-12 and IL-18 are increased and stimulate IFN-γ production in sarcoid lungs. J Immunol 2001; 166: 642-9.
16. Greene CM, Meachery G, Taggart CC, et al: Role of IL-18 in CD4+ T lymphocyte activation in sarcoidosis. J Immunol 2000; 165: 4718-24.
17. Esfandiari E, McInnes IB, Lindop G, et al: A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease. J Immunol 2001; 167: 5338-47.
18. Pizarro TT, Michie MH, Bentz M, et al: IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J Immunol 1999; 162: 6829-35.
19. Schaaf BM, Seizer U, Pravica V, Aries SP, Zabel P: Tumor necrosis factor-α - 308 promoter gene polymorphism and increased tumor necrosis factor serum bioactivity in farmer's lung patients. Am J Respir Crit Care Med 2001; 163; 379-82.
20. Denis M: Proinflammatory cytokines in hypersensitivity pneumonitis. Am J Respir Crit Care Med 1995; 151: 164-9.
21. Sugiyama Y, Kasahara T, Mukaida N, Matsushima K, Kitamura S: Chemokines in bronchoalveolar lavage fluid in summer-type hypersensitivity pneumonitis. Eur Respir J 1995; 8(7): 1084-90.
22. Gudmundsson G, Hunninghake GW: Interferon-gamma is necessary for the expression of hypersensitivity pneumonitis. J Clin Invest 1997; 99(10): 2386-90.
23. Schuyler M, Gott K, Cherne A, Edwards B: Th1 CD4+ cells adoptively transfer experimental hypersensitivity pneumonitis. Cell Immunol 1997; 177: 169-75.
24. Kim DS, Jeno YG, Skim TS, et al: The value of interleukin-12 as an activity marker of pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17: 271-6.
25. Moller DR, Forman JD, Liu MC, et al: Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 1996; 56: 4952-60.
26. Taha RA, Minshall EM, Olivernstein R, et al: Increased expression of IL-12 receptor mRNA in active pulmonary tuberculosis and sarcoidosis. Am J Respir Care Med 1999; 160: 1119-23.
27. Cameron LA, Taha RA, Tsicopoulos A, et al: Airway epithelium expression of interleukin-18. Eur Respir J 1999; 14: 553-9.
28. Nielsen OH, Kirman I, Rudiger N, Hendel J, Vainer B: Upregulation of interleukin-12 and IL-17 in active inflammatory bowel disease. Scand J Gastroenterol 2003; 38(2): 180-5.
29. Tsutsui H, Matsui K, Okamura H, Nakanishi K: Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol Rev 2000; 174: 192-209.
30. Alastair Gracie J, Forsey RJ, Chan WL, et al: A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 1999; 104: 1393-1401.